Since the beginning of the Coronavirus pandemic in India in March 2020, the chaos thereafter has not yet condensed. The number of cases are continuously on the rise with the hope to settle soon. Meanwhile, several Indian companies have been working on the coronavirus cure, aka, coronavirus vaccine. The medicine for corona in india are yet on trial levels but the other thing helping most is the Ayurvedic ways to boost immunity.
Covid-19 was first detected in Wuhan, China in December 2019. It has since affected nearly 21 million people worldwide and has killed over 7 lakh people as of August 2020. Since then, the FDA has issued two emergency-use authorizations for COVID-19 treatments – Hydroxychloroquine sulfate and chloroquine phosphate.
No drugs or vaccines so far have received FDA approval for medicine for corona in india and so, several pharmaceutical companies are putting together their resources from R&D to create a vaccine to cure coronavirus.
Here are companies working on corona vaccine news in India –
Patanjali corona medicine news – Patanjali recently launched a medicine in India called, ‘Divya Coronil tablet’. Although it hasn’t yet been confirmed to effectively help COVID-19 patients, the drug is set to have jointly been made by Patanjali Research Institute and National Institute of Medicine Science, Jaipur. Though this was just crazy news for most, the medicine by Patanjali was reported to work well as an immunity booster.
Glenmark Pharmaceuticals – Aside from Patanjali corona medicine news, on 22 June, Glenmark Pharma received a DCGI approval to launch its new antiviral medicine, Favipiravir. This medicine is being used for treatment of patients with mild to moderate Covid-19 patients. The company on 26 May also announced the beginning of a new phase 3 clinical trial for patients of moderate Covid-19. Check out more corona vaccine news in India below.
Hetero Labs – Hetero Labs also got a nod to manufacture and sell ‘Remdesivir’. The use of the drug has only been allowed in ‘restricted emergency use’. It is also advised to be given to COVID-19 patients with moderated symptoms.
Cipla – Cipla got a nod to manufacture and sell ‘Remdesivir’. With ‘restricted emergency use’ only, the company has also been advised to give this medicine to COVID-19 patients with moderated symptoms. There are many more companies working on medicine for corona in india.
Sun Pharmaceutical – Sun Pharma received DCGI approval for clinical trial of nafamostat mesylate on COVID-19 patients.
Biocon Biologics India – Biocon Biologics started conducting trials from June 1 onwards. This company also received DCGI approval for emergency use of ‘CytoSorb’ to treat critical COVID-19 patients near.
Zydus Cadila
Zydus Cadila is constantly working towards an accelerated vaccine research programme that can fight COVID-19. The company has adopted a two-pronged approach for the development of a vaccine.
Serum Institute of India
When it comes to Corona medicine latest news India, the Serum Institute of India partnered with AstraZeneca on June 4. The company is set to produce around 400 million doses of coronavirus vaccine by the end of 2020. The company has also tied-up with Codagenix to develop a live attenuated vaccine.
Bharat Biotech International
Bharat Biotech International collaborated with the Indian Council for Medical Research to develop a COVID-19 vaccine.
Indian immunologicals
Another corona vaccine news in India is that Indian Immunologicals has collaborated with the Griffith University of Australia to develop a Coronavirus vaccine, using the latest codon De-optimization technology.
Mynvax
Mynvax is a biotechnology startup involved in making next-generation flu vaccines in India. This startup is situated at the Indian Institute of Science, Bangalore and has taken up the responsibility of making the COVID-19 virus. It is developing an indigenous vaccine to prevent COVID-19 infections.
Auro vaccines and Gennova Bio pharmaceuticals
Yet another corona vaccine news in India. Auro Vaccines and Gennova Bio pharmaceuticals also announced their entry into the COVID-19 vaccine development race.
Vaccine candidate from Panacea Biotec
The yet-unnamed vaccine is being developed by Panacea Biotec which has set up a JV firm in Ireland with US-based Refana Inc for the same purpose. The company will manufacture over 500 million doses of the Covid-19 candidate vaccine. Still looking for Corona medicine latest news India? Well, the company said that over 40 million doses are expected to be available for delivery early next year.
Biological E
The vaccine candidate being developed by Biological E is currently in pre-clinical trial levels.
Some other medicines being used to treat coronavirus in India include:
- Cipremi
- FabiFlu
- Covifor
- Hydroxychloroquine
- Remdesivir
- Lopinavir/ritonavir
- Baloxavir marboxil
- Darunavir
- Ribavirin + IFN beta Galidesawer
- Oseltamivir
- Umifenovir
- Camostat mesylate
- Ruxolitinib
- Interferon beta
Conclusion: A cure for coronavirus is yet to be released in the market, although there are medications that have been reported helpful in curing patients with mild symptoms. Make sure you keep yourself and your loved ones informed about all Corona medicine latest news India.
